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ABSTRACT
Background: Psychological stress has a recognized association with asthma symptoms. Using a murine
model of allergic asthma, we recently demonstrated the involvement of μ-opioid receptors (MORs) in the cen-
tral nervous system in the stress-induced exacerbation of airway inflammation. However, the involvement of
MORs on neurons and immunological alterations in the stress asthma model remain unclear.
Methods: MOR-knockout (MORKO) mice that express MORs only on noradrenergic and adrenergic neurons
(MORKOTg mice) were produced and characterized for stress responses. Sensitized mice inhaled antigen
and were then subjected to restraint stress. After a second antigen inhalation, bronchoalveolar lavage cells
were counted. Before the second inhalation, bronchial lymph node (BLN) cells and splenocytes from stressed
and non-stressed mice were cultured with antigen, and cytokine levels and the proportions of T cell subsets
were measured.
Results: Stress-induced worsening of allergic airway inflammation was observed in wild-type and MORKOTg
mice but not MORKO mice. In wild-type stressed mice, IFN-γIL-4 ratios in cell culture supernatants and the
proportion of regulatory T cells in BLN cell populations were significantly lower than those in non-stressed mice.
These differences in BLN cells were not observed between the stressed and non-stressed MORKO mice. Re-
straint stress had no effect on cytokine production or T cell subsets in splenocytes.
Conclusions: Restraint stress aggravated allergic airway inflammation in association with alterations in local
immunity characterized by greater Th2-associated cytokine production and a reduced development of regula-
tory T cells, mediated by MORs.
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INTRODUCTION
Bronchial asthma is a chronic airway inflammatory
disease characterized by the accumulation and activa-
tion of inflammatory cells, such as eosinophils and
mast cells, in the bronchial wall and airway lumen. In-
flammatory mediators released from these cells upon
stimulation, such as arachidonic acid metabolites and
reactive oxygen species, induce the airway narrowing
and airway hyper-responsiveness observed in asth-
matics. Type 2 CD4+ T (Th2) cells and Th2-biased cy-
tokines, such as IL-4, IL-5 and IL-13, play a central
Allergology International. 2012;61:245-258
ORIGINAL ARTICLE
1Department of Pathophysiology, 3Department of Physiology and
Anatomy, Tohoku Pharmaceutical University, 4Department of Bio-
logical Psychiatry, Tohoku University Graduate School of Medi-
cine, 5Division of Respiratory Medicine, Airway Institute in Sendai,
Miyagi and 2Department of Pharmacology, Graduate School of
Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan.
Authors’ contributions: KO and SI contributed equally to this work.
Conflict of interest: No potential conflict of interest was disclosed.
Correspondence: Isao Ohno, Department of Pathophysiology, To-
hoku Pharmaceutical University, 4−4−1 Komatsushima, Aoba-ku,
Sendai, Miyagi 981−8558, Japan.
Email: iohno@tohoku−pharm.ac.jp
Received 20 January 2011. Accepted for publication 25 August
2011.
2012 Japanese Society of Allergology
DOI: 10.2332allergolint.11-OA-0304
Okuyama K et al.
246 Allergology International Vol 61, No2, 2012 www.jsaweb.jp
role in regulating the behavior of inflammatory cells
in asthmatic airways. It has been proposed that
interferon-γ (IFN-γ)-producing type 1 CD4+ T (Th1)
cells inhibit the development of allergic diseases by
counterbalancing the proliferation and development
of Th2 cells, depending on the stage of inflamma-
tion.1-4
CD4+CD25+ regulatory T (Treg) cells play a critical
role in the immune balance network by suppressing
or limiting effector immune responses against inner
and external insults, for example, preventing organ-
specific autoimmunity and allograft rejection as well
as maintaining self-tolerance.5-8 Recent studies have
demonstrated that the failure of Treg cells to sup-
press Th2-mediated immune responses to innocuous
inhaled antigens leads to an inappropriate balance be-
tween allergen activation of Treg cells and effector
Th2 responses, resulting in the development and
maintenance of asthmatic airway inflammation char-
acterized by uncontrolled Th2-biased immune re-
sponses.9-11
A number of clinical studies have demonstrated an
association between psychological stress and asthma
symptom aggravation.12,13 For example, 20-35% of
asthmatics experience an exacerbation of their symp-
toms during periods of stress.14 In childhood asthma,
high levels of chronic stress combined with an
acutely negative life events have been shown to in-
crease the risk of asthma attacks.15 Furthermore, psy-
chological stress has effects on the inflammatory and
immune responses implicated in asthma, such as Th2
cytokines. For example, chronic stress caused by aca-
demic examinations has been shown to increase IL-5
production and eosinophil accumulation after antigen
inhalation in college students with mild asthma.16,17
However, the precise mechanisms by which psycho-
logical stress aggravates Th2 immune responses re-
main to be clarified.
Psychological stress upregulates the production
of endogenous opioids, including endorphins, enke-
phalins and dynorphins. These endogenous opioids
exert their effects, such as analgesia, neuroendocrine
function and immunoregulation, by binding to opioid
receptors consisting of three subtypes, μ, δ and κ.18,19
We recently established a murine model of psycho-
logical stress-induced asthma exacerbation in which
allergen-induced airway inflammation in restraint-
stressed mice was more severe than in non-stressed
mice. This increased airway inflammation in the
restraint-stressed mice was associated with higher
levels of Th2 cytokines. Using this model, we have
demonstrated that μ-opioid receptors (MORs) in the
central nervous system (CNS) are involved in psycho-
logical stress-induced asthma exacerbation.20,21 How-
ever, MORs are expressed not only on neurons but
also on several other cell types, including lympho-
cytes, and the function of MORs on these cells have
been extensively studied.22-25
Therefore, we first aimed to confirm the involve-
ment of neuron MORs in the aggravation of allergic
airway inflammation evoked by the stress exposure,
using mice that express MORs exclusively on neu-
rons. Then we hypothesized that the aggravation of
Th2 responses observed in psychological stress-
induced asthma exacerbation may result from a fail-
ure in the development of Treg cells in airways and
that MORs might be involved in these immune altera-
tions. To address this hypothesis, we examined
antigen-induced Th1, Th2 and regulatory cytokine
production and T cell subset proportions in popula-
tions of bronchial lymph node (BLN) cells and
splenocytes from wild-type and MOR-gene-knockout
(MORKO) mice exposed to restraint stress.
METHODS
ANIMALS
Specific pathogen-free female C57BL6 (B6) mice
were purchased from Japan SLC (Hamamatsu, Ja-
pan). MORKO mice were generated and backcrossed
with B6 mice as described previously.26,27 MOR-
transgenic MORKO (MORKOTg) mice were pro-
duced as discussed below. Animals were housed un-
der a 12 h lightdark cycle with a constant tempera-
ture (22 ± 2℃). Sterilized food and water were avail-
able ad libitum. All experiments described below
were approved by the Committee of Animal Experi-
ments at Tohoku Pharmaceutical University and To-
hoku University and conformed to the committee
guidelines of each university.
PLASMID CONSTRUCT AND PRODUCTION OF
MORKOTg MICE
The plasmid pDIL,28 which contains the human
dopamine β-hydroxylase (DBH) gene promoter con-
nected to a cDNA fragment encoding the human in-
terleukin 2 receptor α subunit (IL-2Rα), was donated
by Dr. K. Kobayashi (Fukushima Medical University
School of Medicine, Fukushima, Japan). We replaced
the cDNA part of pDIL with a cDNA fragment encod-
ing the human μ-opioid receptor gene, which we had
previously cloned.29 Figure 1 shows the transgene
construct used in this study. The construct was mi-
croinjected into fertilized B6 mouse eggs, which were
implanted into pseudopregnant female mice. Microin-
jections were conducted by Central Laboratories of
Experimental Animals (Kawasaki, Japan) and YSNT
Inst., Inc. (Shimotsuga, Japan). Successful integration
of the transgene was confirmed by Southern blot
analysis of tail DNA. The transgenic mice were then
crossed with homozygous MORKO mice with a B6
genetic background23 to obtain the Tg mouse (F1 off-
spring: heterozygous MORKOTg). Homozygous
MORKOTg mice were produced by crossing the F1
offspring with homozygous MORKO mice.
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Fig.　1　Human DBH promoter―human MOR cDNA fusion gene in the plasmid. This con-
struct includes the 4 kb DNA fragment of the human DBH promoter in addition to the rabbit 
β-globin second intron, human MOR cDNA, rabbit β-globin polyadenylation signal, and 
SV40 early gene polyadenylation signal.
Human DBH gene promoter (4 kb)
Human
μ-opioid receptor
β-Globin
intron
β-Globin/SV40
Poly A signals
1.0 (kb)
In situ HYBRIDIZATION
Brains were removed quickly and frozen in powdered
dry ice. Coronal sections (16 μm) were prepared in a
cryostat, thaw-mounted onto gelatin-coated slides and
stored at -80℃ until in situ hybridization was con-
ducted. Because the coding regions of human and
mouse MOR mRNA are highly homologous, 5’-non-
coding regions of MOR cDNA were used as the tem-
plates to synthesize the RNA probes. 35S-labeled an-
tisense and sense RNA probes for the in situ hybridi-
zation were synthesized in the presence of [α35S]
UTP (30 TBqmmol, Amersham, Buckingham, NY,
USA), using a T3 RNA polymerase (Promega, Madi-
son, WI, USA). For the in situ hybridization, sections
were fixed in 4% formalin in 10 mM phosphate-
buffered saline for 30 min, treated with proteinase K
(0.5 μgml) for 10 min and immersed in 0.25% acetic
anhydride in 0.1 M triethanolaminesaline for 10 min.
After dehydration in an ethanol series (70, 85, 95,
100%), prehybridization was carried out at 55℃ for 1
hr in the following buffer: 50% formamide, 4x SSC (1x
SSC = 150 mM NaCl, 15 mM tri-sodium citrate, pH
7.0), 5x Denhardt’s solution, 10 mM EDTA, 250 μg
ml yeast tRNA, 20 mM dithiothreitol (DTT) and 500
μgml heat-denatured salmon sperm DNA, and the
sections were then hybridized to the antisense or
sense RNA probe at 55℃ for 17 h. For the hybridiza-
tion, 10% dextran sulfate was added to the buffer. Af-
ter the hybridization, sections were washed four
times in 2x SSC10 mM DTT for 10 min at 55℃, incu-
bated with RNase A (50 μgml in 0.5 M NaCl10 mM
Tris1 mM EDTA, pH 8.0) for 30 min at 37℃ and
then washed twice in 50% formamide2x SSC10 mM
DTT for 30 min at 55℃. The sections were dehy-
drated in the ethanol series and dried. The slides
were exposed to Hyperfilm-β max (Amersham) and
then dipped in autoradiographic emulsion NTB-3
(Kodak, Rochester, NY, USA) diluted 1 : 1 with water.
After 3 weeks of exposure, the slides were developed
with D-19 (Kodak) and counterstained with cresyl
violet.
LIGAND BINDING AND AUTORADIOGRAPHY
Brains and adrenal glands were removed from wild-
type, MORKO and MORKOTg mice and quickly fro-
zen at -80℃. The brains were cryosectioned at 10 μm
and thaw-mounted onto gelatin-coated slides. Tissue
sections were preincubated with 50 mM Tris buffer
(pH 7.4) containing 10 mM MgCl2 and 1 mM EDTA
for 10 min at 25℃. The sections were then incubated
with 2 nM [3H]DAMGO (50.5 Cimmol) (DuPont-
New England Nuclear, Boston, MA, USA) for 60 min
at 25℃. DAMGO [D-Ala2, N-MePhe4, Gly-ol5]
enkephalin is a MOR-selective agonist. After the incu-
bation, sections were washed twice in fresh buffer for
120 min at 25℃ and in deionized water for 5 min at
4℃ and then dried for 60 min at 4℃. Sections were
exposed to IP-film for 4 weeks and analyzed using the
BAS3100II system (Fujix, Tokyo, Japan).
TAIL SUSPENSION TESTING
For tail suspension testing, mice were taped by their
tail to a metal hook in a test chamber (20 × 20 × 25
cm) made of white plastic walls and floor. Each hook
was connected to a computerized strain gauge that
was adjusted to detect all movements of the animals
(Tail suspension system; Neuroscience Inc., Osaka,
Japan). The total duration of the immobility testing
was 15 min.
STRESS PROCEDURES AND CORTICOSTER-
ONE EIA
First, blood samples were obtained from naive wild-
type, MORKO and MORKOTg mice tail veins. Next,
after a 3-day interval, the 15-minute tail suspension
procedure was performed on these mice. Blood sam-
ples were obtained again at 30 min after the tail sus-
pension testing. Finally, after a 1-day interval, the
physical restraint procedure was performed on these
mice. For the restraint stress procedure, mice were
placed in a 50 ml conical centrifuge tube with multi-
ple ventilation holes. Mice were restrained vertically
in the tube for 12 h, followed by 12 h of rest during
which food and water were available ad libitum. This
restraint allowed the mice to rotate from a supine to
prone position but not to turn their heads toward
their tails or take food and water. Restraint stress is
generally considered to induce psychological stress
in animals.30 Mice were restrained for two cycles as
described, and blood samples were then obtained. All
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Fig.　2　Diagrammatic representation of the protocols. (A) Isolation of spleen, BLNs and BAL fl uid. (B) Culture of 
splenocytes and BLN cells.
A
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34 35 37 40 (days)
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for T cell subsets
Supernatants: ELISA for measurement
of cytokine contents
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OVA/Alum
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blood samples were immediately centrifuged for 20
min at 1,000 g, and obtained plasma samples were
then stored at -80℃ until the analysis. Plasma corti-
costerone levels were determined using a Corti-
costerone Enzyme Immunoassay Kit (Assay Design
Inc., Ann Arbor, MI, USA).
PROTOCOLS FOR SENSITIZATION, CHAL-
LENGE AND STRESS EXPOSURE
Our previously published murine model of stress-
induced exacerbation of allergic airway inflamma-
tion21 was used in this study. Briefly, mice 6-8 weeks
old were sensitized by intraperitoneal injections of
chicken ovalbumin (OVA) (Grade V, Sigma, St.
Louis, MO, USA) (8 μgmouse) adsorbed with alumi-
num hydroxide (Wako Pure Chemical Industries,
Osaka, Japan) (4 mgmouse) on days 0 and 5. For re-
straint stress, each mouse was placed in a 50-ml coni-
cal centrifuge tube as described above for 6 h per
day. On day 30, stressed mice in the 50-ml conical
centrifuge tubes were left in plastic chambers for 6 h.
For the first hour of this period, aerosolized OVA was
pumped through the chambers to expose the mice in
the tubes to OVA. Stressed mice were subjected to
the restraint stress for 6 consecutive days, on days 31
to 36, at the same time each day. Non-stressed mice
were only deprived of food and water for the same pe-
riod as the stressed mice were exposed to stress.
Food and water deprivation has been used as a non-
stress condition in other rodent experiments investi-
gating the effects of restraint stress.31,32 On day 37,
stressed and non-stressed mice were challenged with
aerosolized OVA. On day 40, their lungs were lav-
aged twice with an injection of 0.25 ml of cold saline
through the trachea, as described previously, and the
recovered bronchoalveolar lavage (BAL) fluid was
pooled. Approximately 0.4 ml of instilled fluid was
consistently recovered from each mouse. BAL fluid
was processed for counting total cells and cell differ-
entials (Fig. 2A). In other experiments, stressed and
non-stressed mice were sacrificed on day 37 to collect
spleen and BLNs (Fig. 2A).
PREPARATION AND CULTURE OF SPLENO-
CYTES AND BLN CELLS
Splenocytes and BLN cells were prepared and cul-
tured as previously described.33,34 For each experi-
ment, BLN cells were prepared from BLNs collected
from 6-8 wild-type mice and 5 MORKO mice, and
splenocytes were prepared from the spleen of one
mouse. Splenocytes and BLN cells were suspended
at 5 × 106 cellsml in complete media consisting of
RPMI 1640 (Gibco BRL, Rockville, MD, USA) supple-
mented with 10% fetal bovine serum (ICN Biomedi-
cals, Inc., Aurosa, OH, USA), 55 μM 2-mercapto-
ethanol (Wako Pure Chemical Industries), 2 mgml
NaHCO3, 50 Uml penicillin G (Meiji Seika, Tokyo,
Japan), 50 μgml streptomycin sulphate (Meiji Seika)
and 2 mM L-glutamine (Wako Pure Chemical Indus-
tries). Cell viability of the suspension was more than
Immune Alterations in Stress Asthma
Allergology International Vol 61, No2, 2012 www.jsaweb.jp 249
98%, as determined by trypan blue dye exclusion. The
cells were cultured at 1 × 107 cellswell in 24-well cul-
ture plates (MICROPlate, Asahi Techno Glass, Chiba,
Japan) in the presence or absence of OVA (200 μg
ml) for 3 days. After the culture, the number of viable
cells was counted, and the samples were centrifuged.
The supernatants were stored at -80℃ for cytokine
measurements using an enzyme-linked immunosorb-
ent assay (ELISA), and the cells were subjected to
lymphocyte compartment analysis by flow cytometry
before and after the culture (Fig. 2B).
CYTOKINE MEASUREMENTS
IL-4, IL-5, IL-10, IL-13, IFN-γ and TGF-β1 levels in the
supernatant were measured using specific ELISA kits
(R&D systems, Minneapolis, MN, USA) according to
the manufacturer’s protocol. The sensitivity of detec-
tion was 2 pgml for IL-4, 7 pgml for IL-5, 4 pgml
for IL-10, 1.5 pgml for IL-13, 2 pgml for IFN-γ and
2.9 pgml for TGF-β1. Because IFN-γ and IL-4 are
classical examples of antagonistic signature cytokines
for Th1 and Th2 activity, respectively, the Th1Th2
balance was monitored by IFN-γIL-4 ratio,35 which
was calculated with the values of these two cytokines
obtained from the same experiment.
FLOW CYTOMETRIC ANALYSIS
CD3+CD4+, CD3+CD4+T1ST2+ and Treg compart-
ments of splenocytes and BLN cells were analyzed as
previously described.34 Briefly, the cells were pre-
incubated with anti-CD16CD32 (FCγIIIII receptor;
BD Biosciences PharMingen, San Diego, CA, USA)
to reduce nonspecific binding of the subsequent anti-
bodies. Anti-T1ST2-fluorescein isothiocyanate (clone
DJ8, 0.8 μg106 cells) (Morwell Diagnostic, Zurich,
Switzerland), anti-CD3e-allophycocyanin (clone 145-
2C11, 0.8 μg106 cells) (BD Biosciences PharMin-
gen), anti-CD4-R-phycoerythrin (clone GK1.5, 0.5 μg
106 cells) (BD Biosciences PharMingen) or isotype
control antibodies were added directly to the cells.
T1ST2 was employed as a surface marker for Th2
cells because it is preferentially expressed on the sur-
face of murine Th2 cells and plays an important role
in the activation of Th2 cells, including proliferation
and Th2 cytokine production.36,37 Treg cells were
identified as CD4+CD25+ cells, using a mouse regula-
tory T cell staining kit (eBioscience, San Diego, CA,
USA) according to the manufacturer’s protocol. Cells
were counted on a FACScan (BD Biosciences
PharMingen), and the analyses were performed us-
ing Cell Quest (BD Biosciences PharMingen).
DATA ANALYSIS
In the behavior analyses, significant differences were
statistically evaluated using an analysis of variance
(ANOVA) followed by the Bonferroni post hoc test or
a paired t-test. Significant differences between two
groups were determined using the nonparametric
Mann-Whitney U-test. These analyses were per-
formed using Prism4 (GraphPad Software, San Di-
ego, CA, USA). A p value of less than 0.05 was consid-
ered significant.
RESULTS
ANALYSIS OF TRANSGENE mRNA AND FUNC-
TIONAL MOR PROTEIN EXPRESSION
The expression of the human MOR was investigated
in MORKOTg mice by in situ hybridization with se-
lective probes for mouse and human MOR mRNA. In
brainstem sections, the specific expression of human
MOR mRNA was found in locus ceruleus (LC) re-
gions in the MORKOTg mouse (Fig. 3A, B). Lower
expression levels of the human MOR mRNA were
found in other brain regions. The lack of detection of
the expression signals in both wild-type mouse by the
human selective probe and the MORKOTg mouse
by the mouse selective probe confirmed the expres-
sion of human MOR mRNA by the transgene. Next,
the functional expression of MOR protein was con-
firmed in MORKOTg mice by [3H]DAMGO binding
(Fig. 3C). In MORKOTg mice, the [3H]DAMGO
binding sites were specifically found in the cortex and
thalamus, which were quite different from those in
wild-type mice.
TAIL SUSPENSION TEST
Immobility times in the 15-min tail suspension assay
were analyzed in wild-type, MORKO, and MORKO
Tg mice (Fig. 4A, B). Although all the studied geno-
types showed a time-dependent increase in immobil-
ity time, there were significant differences in the
manner of this increase among the genotypes (two-
way repeated measures ANOVA: p < 0.05; F = 5.13;
df = 2.560). MORKO mice showed significantly less
immobility compared with wild-type mice from 5 to 10
min after initiation of the tail suspension (p < 0.05).
Interestingly, this decreased immobility in MORKO
mice was not found in MORKOTg mice. MORKO
Tg mice showed no difference from wild-type mice
but did show a significant difference compared with
MORKO mice (p < 0.05) in immobility time (Fig. 4B).
STRESS-INDUCED CORTICOSTERONE RE-
LEASE
We analyzed both tail suspension and restrained
stress-induced changes in plasma corticosterone con-
centration in wild-type, MORKO, and MORKOTg
mice (Fig. 5). Both tail suspension and restraint
stress significantly increased plasma corticosterone
concentrations in wild-type (paired t-test: p < 0.0005,
t = -5.68, p < 0.0001, t = -7.56, respectively), MORKO
(paired t-test: p < 0.0005, t = -4.54, p < 0.0001, t = -9.84,
respectively), and MORKOTg mice (paired t-test:
p < 0.0001, t = -7.39, p < 0.0001, t = -24.01, respec-
tively). In addition, the ANOVA showed significant
differences among these genotypes in changes in
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Fig.　3　Autoradiographs of MOR mRNA expression and [3H]DAMGO binding sites. Macro(A)- and micro(B)-autora-
diographs of in situ hybridization for mouse and human MOR mRNA showed the LC region-specifi c expression of 
human MOR mRNA in coronal sections (bregma -5.5 mm) of the MORKO/Tg mouse. White arrows indicate the LC 
regions. (C) Autoradiographic distribution of [3H]DAMGO binding sites in coronal brain slices of wild-type, MORKO, 
and MORKO/Tg mice. Sections were taken through the brainstem: LC (bregma +5.5 mm: upper panel) and thala-
mus: cortex (bregma -0.7 mm: lower panel).
A BMacro autoradiography
C Autoradiographic distribution of MORs
Wild-type mouse MORKO mouse MORKO/Tg mouse
Coronal slice
bregma -5.5 mm
Coronal slice
bregma +0.7 mm
Wild-type mouse
mouse gene
selective probe
(mp)
human gene
selective probe
(hp)
mp
hp
MORKO/Tg mouse Wild-type mouse MORKO/Tg mouse
Micro autoradiography
Fig.　4　Immobility in wild-type, MORKO, and MORKO/Tg mice in the 15-min tail suspension test. (A) Immobility 
times were measured in wild-type (n = 17), MORKO (n = 13), and MORKO/Tg (n = 13) mice. (B) AUC of the im-
mobility times over 5 min in the tail suspension tests. ##, ### p < 0.01, 0.001, indicating a signifi cant difference 
from the corresponding value in MORKO mice. Data are expressed as the mean ± SEM.
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Fig.　5　Stress-induced increase in plasma corticosterone 
concentrations in wild-type, MORKO, and MORKO/Tg mice. 
Plasma corticosterone levels were analyzed in wild-type (n = 
11), MORKO (n = 17), and MORKO/Tg (n = 13) mice before 
any test, after the tail suspension test, and after the restraint 
stress. #p < 0.05, showing a signifi cant difference from the 
corresponding value in MORKO mice. Data are expressed 
as the mean ± SEM.
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Fig.　6　Comparison of cell numbers in BAL fl uids between 
stressed and non-stressed mice. The numbers of total cells 
(Total), macrophages (Mϕ), eosinophils (Eo), neutrophils 
(Neu) and lymphocytes (Lym) in BAL fl uids were counted for 
non-stressed (open bars) and stressed (hatched bars) wild-
type (5 and 6, respectively, in A), MORKO (7 and 8, respec-
tively, in B) and MORKO/Tg (5 and 6, respectively, in C) 
mice three days after the 2nd OVA inhalation (day 40). Data 
are expressed as the mean ± S.D. *p < 0.05 and **p < 0.01 
compared to non-stressed mice.
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plasma corticosterone concentration (tail suspension
stress: p < 0.0005; F = 11.14; df = 2.38; restrained
stress: p < 0.0001; F = 14.04; df = 2.38). MORKO mice
showed significantly lower plasma corticosterone
concentrations compared with wild-type mice after
both the tail suspension and restraint stress proce-
dure (p < 0.05). Furthermore, MORKOTg mice
showed the same level of increase in corticosterone
concentration compared to wild-type mice, and this
change was significantly different from MORKO mice
(p < 0.05).
RESTRAINT STRESS-INDUCED AGGRAVATION
OF ALLERGIC AIRWAY INFLAMMATION IN
MORKOTgMICE
As previously demonstrated,21 the stress-induced
worsening of allergic airway inflammation observed
in wild-type mice (non-stress vs. stress: total cells,
134.5 ± 57.1 vs. 340.6 ± 164.8 × 104 cellsml, p < 0.01;
eosinophils, 82.0 ± 35.8 vs. 262.4 ± 128.0 × 104 cells
ml, p < 0.01; lymphocytes, 16.7 ± 7.7 vs. 39.0 ± 30.1 ×
104 cellsml, p < 0.01) (Fig. 6A) was not observed in
the MORKO mice (Fig. 6B). However, as shown in
Figure 6C, the numbers of total cells and eosinophils
in BAL fluid three days after the second antigen inha-
lation in stressed MORKOTg mice were signifi-
cantly higher than those in non-stressed MORKOTg
mice (non-stress vs. stress: total cells, 170.7 ± 67.8 vs.
320.6 ± 62.5 × 104 cellsml, p < 0.01; eosinophils,
124.0 ± 43.7 vs. 251.5 ± 57.2 × 104 cellsml, p < 0.01),
although the difference in the number of lympho-
cytes did not reach significance (non-stress vs. stress:
27.5 ± 23.4 vs. 41.8 ± 15.5 × 104 cellsml).
THE EFFECT OF RESTRAINT STRESS ON CY-
TOKINE PRODUCTION BY SPLENOCYTES AND
BLN CELLS
The levels of the Th2 cytokines IL-4, IL-5 and IL-13 in
splenocyte culture supernatants stimulated with OVA
were not significantly different between stressed and
non-stressed wild-type mice (n = 8 for IL-4, n = 7 for
IL-5 and n = 8 for IL-13). Similarly, the production of
the Th1 cytokine IFN-γ and the regulatory cytokines
IL-10 and TGF-β1 by OVA-stimulated splenocytes was
not significantly influenced by stress exposure (n =
10 for IFN-γ, n = 10 for IL-10 and n = 9 for TGF-β1)
(Table 1). IFN-γIL-4 ratio, as a measure of the Th1
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Fig.　7　IFN-γ/IL-4 ratio in splenocytes and BLN cells. The IFN-γ/IL-4 ratio was calculated as 
described in “Methods” in splenocytes (A) and BLN cells (B) from non-stressed (open bars) 
and stressed (hatched bars) wild-type mice. The numbers of samples for each condition are 
shown in parentheses. Data are expressed as the mean ± S.D. **p < 0.01.
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Table　1　Cytokine production by splenocytes and BLN cells
splenocytes BLN cells
OVA (-) OVA (+) OVA (-) OVA (+)
IL-4
  9.4 ± 2.6†   49.4 ± 23.8   8.3 ± 1.0   74.0 ± 24.6
  7.9 ± 6.1   41.7 ± 35.5   8.6 ± 3.2  118.2 ± 60.2
IL-5
  0.0 ± 0.0 1504.4 ± 1094.0 244.9 ± 108.4 3110.4 ± 529.9
  2.9 ± 4.6 1430.8 ± 1075.6 184.1 ± 93.6 3645.0 ± 998.6
IL-13
 67.0 ± 46.8 6110.4 ± 3570.7 440.1 ± 230.6 5512.2 ± 1079.3
102.0 ± 73.5 5244.8 ± 2477.4 584.3 ± 286.1 6885.0 ± 2554.8
IFN-γ 100.0 ± 104.7 1681.2 ± 629.3   8.0 ± 4.7  125.3 ± 39.0
338.0 ± 303.8 1116.0 ± 606.9   8.8 ± 5.6  102.1 ± 47.3
IL-10
 11.4 ± 4.9  934.0 ± 540.0  44.8 ± 27.1 1065.0 ± 106.9
 15.2 ± 7.1  730.6 ± 458.5  46.9 ± 17.6 1160.0 ± 255.7
TGF-β1
370.8 ± 169.8  453.8 ± 222.5  54.0 ± 59.3  193.1 ± 121.0
391.3 ± 239.9  411.1 ± 271.8   0.0 ± 0.0  148.2 ± 58.1
†mean ± SD (pg/ml) in non-stressed mice
mean ± SD (pg/ml) in stressed mice
Th2 balance, in the culture supernatants was not sig-
nificantly different between stressed (n = 8) and non-
stressed (n = 8) wild-type mice (Fig. 7A). There were
no significant differences between non-stressed and
stressed wild-type mice in cytokine levels in the cul-
ture supernatants without OVA (n = 6 for IL-4, IL-5,
IL-13, IFN-γ, IL-10 and TGF-β1) (Table 1).
Similar to the results for cytokine production by
splenocytes, stress exposure did not significantly af-
fect cytokine production by BLN cells cultured with
(n = 6 for IL-4, n = 5 for IL-5, n = 6 for IL-13, n = 6 for
IFN-γ, IL-10 and TGF-β1) or without (n = 6 for IL-4,
n = 5 for IL-5, n = 6 for IL-13, n = 6 for IFN-γ, n = 4 for
IL-10 and n = 6 for TGF-β1) OVA (Table 1). However,
the IFN-γIL-4 ratio in the culture supernatants of
BLN cells stimulated with OVA from stressed wild-
type mice was significantly lower than that from non-
stressed wild-type mice (0.7 ± 0.2: n = 6 vs. 1.9 ± 1.0:
n = 6, p < 0.01) (Fig. 7B).
THE EFFECT OF RESTRAINT STRESS ON T
CELL SUBSET PROPORTIONS IN SPLENO-
CYTES AND BLN CELLS
In splenocytes, there was no significant difference in
the numbers of viable cells after culture with OVA be-
tween non-stressed and stressed wild-type mice (data
not shown). In both non-stressed and stressed wild-
type mice, there were significant increases in the pro-
portion of CD3+CD4+ and CD3+CD4+T1ST2+ cells af-
ter culture with OVA. The proportion of these cells in
stressed wild-type mice was not significantly different
from those in non-stressed wild-type mice, either be-
fore (n = 4) or after (n = 5) culture. The proportion of
CD4+CD25+ cells after culture with OVA was not sig-
nificantly increased compared with the percentage
before culture in either non-stressed or stressed wild-
type mice, and there were no significant differences
in the proportion of these cells between stressed and
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Fig.　8　The proportion of T cell subsets in splenocytes and BLN cells. Spleno-
cytes (A) and BLN cells (B) from non-stressed (open bars) and stressed 
(hatched bars) wild-type mice were analyzed for the percentages of CD3+CD4+, 
CD3+CD4+T1/ST2+ and CD4+CD25+ cells before (pre) and 3 days after the cul-
ture with OVA. The numbers of CD3+CD4+, CD3+CD4+T1/ST2+ and 
CD4+CD25+ cells are shown as percentages of the total number of splenocytes 
and BLN cells. The numbers of mice examined and the experiment numbers 
are shown in parentheses in A and B, respectively. Data are expressed as the 
mean ± S.D. *p < 0.05 and **p < 0.01 compared with pre, ##p < 0.01.
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non-stressed wild type mice, either before (n = 4) or
after (n = 5) culture (Fig. 8A).
In BLN cells, there was no significant difference in
the numbers of viable cells after the culture with OVA
between non-stressed and stressed wild-type mice
(data not shown). Similar to splenocytes, culturing
the cells with OVA significantly increased the propor-
tion of CD3+CD4+ and CD3+CD4+T1ST2+ cells from
both non-stressed and stressed wild-type mice. There
were no significant differences in the proportion of
these cells between stressed and non-stressed wild-
type mice, either before (n = 4) or after (n = 6) cul-
ture. Regarding the CD4+CD25+ population in BLN
cells, in both non-stressed and stressed wild-type
mice, the proportion of these cells was significantly
increased after the culture with OVA (non-stressed:
7.3 ± 1.7: n = 6 vs. 1.2 ± 0.5: n = 4 %, p < 0.01, stressed:
5.6 ± 0.2: n = 6 vs. 1.1 ± 0.4: n = 4 %, p < 0.01). Al-
though no significant difference was observed be-
tween the mice in the proportion of CD4+CD25+ cells
before the culture, this proportion in stressed mice
was significantly lower than that from non-stressed
mice after the culture (5.6 ± 0.2: n = 6 vs. 7.3 ± 1.7: n =
6 %, p < 0.01) (Fig. 8B).
ABOLISHMENT OF THE EFFECT OF RESTRAINT
STRESS ON BLN CELLS IN MORKO MICE
The stress-induced aggravation of allergen-mediated
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Fig.　9　IFN-γ/IL-4 ratio and the proportion of CD4+CD25+ cells in BLN cells of MORKO mice. BLN 
cells from non-stressed (open bars) and stressed (hatched bars) MORKO mice were cultured with 
OVA for 3 days. The IFN-γ/IL-4 ratio (A) was calculated as in Figure 7, and the proportion of 
CD4+CD25+ cells was analyzed as in Figure 8. The numbers of experiments for each condition 
are shown in parentheses. Data are expressed as the mean ± S.D. *p < 0.05 and **p < 0.01 com-
pared with pre.
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airway inflammation was abolished in MORKO mice,
as previously reported.21 Therefore, we investigated
whether MOR was involved in the immunological al-
terations observed in BLN cells from stressed wild-
type mice. In contrast to the case of wild-type mice,
the IFN-γIL-4 ratio in the culture supernatants of
OVA-stimulated BLN cells from stressed MORKO
mice (n = 7) was not significantly different from that
of the non-stressed MORKO mice (n = 6) (Fig. 9A).
Similar to wild-type mice, the proportion of CD4+
CD25+ cells from stressed and non-stressed MORKO
mice showed a similar increase after culture with
OVA. However, no significant difference was ob-
served in the proportion of CD4+CD25+ cells between
non-stressed (n = 4) and stressed (n = 4) MORKO
mice (Fig. 9B).
DISCUSSION
In the present study, we produced Tg mice, in which
the expression of MORs is under the control of the
human DBH gene promoter. Furthermore, by mating
these Tg mice with MORKO mice, we produced
MORKOTg mice that express MORs only on norad-
renergic and adrenergic neurons. This human DBH
gene promoter has been previously used for produc-
ing transgenic mice, successfully expressing phenyl-
ethanolamine-N-methyltransferase38 or IL-2Rα28 on
noradrenergic and adrenergic neurons. The expres-
sion of human MOR mRNA in coronal brainstem sec-
tions of MORKOTg mice was mostly limited to the
LC, in which the cell bodies of noradrenergic neu-
rons are congregated. Furthermore, we confirmed
the functional expression of MOR protein on cortex
regions, into which many noradrenergic neurons pro-
ject, in MORKOTg mice. Despite these alterations,
no abnormalities in growth, fertility, or general activ-
ity were detected in MORKOTg mice.
MORKOTg mice also showed the same level of
immobility in the tail suspension test and stress-
induced plasma corticosterone concentrations as
wild-type mice, and these levels were significantly dif-
ferent from MORKO mice. MORKO mice showed a
significantly decreased immobility time in the tail sus-
pension test and a reduced stress-induced change in
plasma corticosterone concentration compared with
wild-type mice, which is consistent with our previous
report.39 These results indicate that the MORs on no-
radrenergic and adrenergic neurons has functional
roles in stress sensibility or responses.
Next, we compared the effect of restraint stress on
allergic airway inflammation between wild-type,
MORKO and MORKOTg mice. We found that the
stress-induced exacerbation of airway inflammation
observed in wild-type mice, which was abrogated in
MORKO mice, was recovered in MORKOTg mice.
These results indicate that MORs on neurons in the
CNS and periphery, in this case noradrenergic and
adrenergic neurons, are involved in the stress-
induced aggravation of allergic airway inflammation.
MORs are expressed not only on neurons but also on
several other types of cells, including lymphocytes,
and the functions of these receptors on lymphocytes
have been extensively studied, including cell differen-
tiation and the production of pro-inflammatory and
Th2 cytokines.22-25 Previously, we demonstrated that
the effect of stress in wild-type mice was completely
Immune Alterations in Stress Asthma
Allergology International Vol 61, No2, 2012 www.jsaweb.jp 255
abolished by the intracerebroventricular injection of
an MOR antagonist, β-funaltrexamine, that selectively
inhibits the activation of MORs in the CNS, but this
abolishment was not seen by the peritoneal injection
of naloxone methiodide, a nonselective opioid recep-
tor antagonist that cannot pass through the blood-
brain barrier.21 The peritoneal injection of naloxone
methiodide would inhibit the activation of MORs on
immune cells and neurons in the periphery. There-
fore, together with our previous findings, the current
results strongly suggest that the effect of restraint
stress on allergic airway inflammation is mediated by
MORs on cells in the CNS, including noradrenergic
and adrenergic neurons, although the involvement of
MORs on immune cells present in the CNS during
the stress exposure cannot be completely excluded.
We have demonstrated for the first time the effects
of restraint stress as psychological stress on allergen-
specific immune responses at the site of inflammation
in a murine model of psychological stress-induced
asthma exacerbations and the involvement of MORs
in these immunological alterations associated with re-
straint stress.
To investigate stress-induced allergen-specific im-
mune responses, we compared cytokine production
profiles and the proportions of T cell subsets in BLN
cell populations from stressed and non-stressed mice.
Levels of Th1, Th2 and regulatory cytokines pro-
duced by BLN cells upon stimulation with the aller-
gen were not significantly different between stressed
and non-stressed mice. However, IFN-γIL-4 ratios in
stressed mice were significantly lower than those in
non-stressed mice, suggesting that restraint stress
shifted the allergic immune response towards a Th2
character. Regarding the T cell subset proportions,
culturing the cells with OVA increased the proportion
of Th2 cells in both groups. However, there was no
significant difference in the proportion of Th2 cells
either before or after the culture with the allergen be-
tween the stressed and non-stressed mice. However,
whereas the proportion of Treg cells increased after
the culture in both groups, the final Treg percentage
in stressed mice was significantly lower than that in
non-stressed mice after the culture. The increase in
the Treg cell population after the exposure to aller-
gen is consistent with the finding by Thunberg S et
al. that allergen provocation increased the number of
CD4+CD25bright Treg cells in asthmatic lungs.40 In the
current study, CD4 and CD25 were used as markers
to identify the Treg population, as in other murine
models of allergic asthma.41-43 The entire population
of CD4+CD25+ T cells, expressing both low and high
CD25 levels, exhibits a regulatory function in
mice.44-46 However, the expression of CD25 after the
culture with antigen could also represent activated
CD4+ cells. Further characterization of more specific
markers, including Foxp3, and inhibitory functions in
CD4+CD25+ cells would be needed to distinguish
Tregs from activated CD4+ cells.
Mental stress has been reported to reduce the
number of Treg cells in peripheral blood in human
subjects. A brief laboratory stressor was shown to
cause a decrease of CD4+Foxp3+ Treg cells in healthy
young males.47 A significant reduction in the propor-
tion of Treg cells was observed in patients with post-
traumatic stress disorder (PTSD) compared to indi-
viduals without PTSD.48 Regarding changes in im-
mune regulation in response to stressors in allergic
subjects, Höglund et al. reported systemic immu-
nological responses to examination stress in healthy
and atopic individuals.49 The ratio of Th1 and Th2 cy-
tokines produced by peripheral blood mononuclear
cells stimulated with PHAPMA was decreased in
response to stress in atopic individuals but not in
controls, similar to our findings. In contrast to our
findings, the proportion of Treg (CD4+CD45RO+
CD25bright) cells in peripheral blood increased in re-
sponse to stress in atopic subjects. However, this in-
crease of Treg cells was also observed in control sub-
jects. The discrepancy in the change in Treg cell pro-
portion may be attributable to sites investigated (sys-
temic or local) or stimulation (with or without aller-
gen), as well to differences in the subjects examined.
The importance of the site and allergen exposure in
the effect of stress on immune regulation is discussed
below.
Deficiency and dysfunction of Treg cells are ob-
served in asthmatics and are thought to be responsi-
ble for Th2-predominant immune responses in
asthma.9-11 The recovery of Treg cell numbers has
been shown to ameliorate allergen-induced airway in-
flammation and hyper-responsiveness in murine mod-
els of allergic asthma,42,43,50 and successful allergen-
specific immunotherapy has been correlated with in-
creased numbers and the activation of allergen-
specific Treg cells.51,52 Furthermore, the presence of
Treg cells in the lungs has been inversely correlated
with eosinophilic airway inflammation in murine mod-
els of allergic asthma.53 Therefore, we assume that
the lower number of Treg cells induced by stressors
might allow more pronounced Th2 responses in
allergen-challenged conditions, resulting in the ag-
gravation of allergic airway inflammation observed in
our model. This interpretation is supported by a re-
port showing that the reconstitution of a T cell reper-
toire with a limited number of Treg cells resulted in
severe Th2-associated inflammatory disease upon the
subsequent transfer of effector T cells.41
Using our stress model, we previously demon-
strated that MORs in the central nervous system
were involved in the stress-induced aggravation of al-
lergic airway inflammation.21 In the current study, the
effect of stress on the IFN-γIL-4 ratio and the num-
ber of Treg cells in BLN cell populations cultured
with allergen was not observed in MORKO mice.
Considering these results, it might be assumed that
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restraint stress evokes an alteration of the immune
responses to allergen through the activation of
MORs, resulting in the exacerbation of allergen-
induced airway inflammation. Although the hypo-
thalamic-pituitary-adrenal axis and the sympathetic
and adrenomedullary system have been proposed as
relevant pathways through which stress modifies in-
flammatoryimmune responses to induce asthma ex-
acerbation,54 the psycho-neuro-immunological cas-
cade involved in the worsening of asthma symptoms
due to psychological stress is not fully understood. In
this study, we have reported for the first time poten-
tial components, MORs and Treg cells, in neurologi-
cal and immunological pathways linking stress to
asthma exacerbation.
Stress is perceived in the brain, which subse-
quently activates physiologic systems in the body. Ac-
cordingly, immunological alterations would be ex-
pected to occur not specifically in BLNs, but also in
the spleen. However, a stress effect on immune re-
sponses to specific antigen was not observed in
splenocytes. Sensitized mice were exposed to aller-
gen by inhalation at the beginning of the stress expo-
sure on day 30; consequently, BLN cells but not
splenocytes were in contact with the allergen during
the period of stress exposure. In this stress model,
when mice were treated with saline by inhalation on
day 30, no significant difference was observed be-
tween the stressed and non-stressed mice in airway
inflammation elicited by the second allergen chal-
lenge on day 37 (data not shown). These findings
suggest that the simultaneous presence of allergen
with immune cells during the stress exposure was re-
quired for the development of stress-induced altered
immune responses to the subsequent allergen stimu-
lation. Immature dendritic cells, having captured al-
lergens, migrate to regional lymph nodes,55 where
they induce different subsets of T cells, including
Treg cells.56,57 Stress might exert some effects on
this induction of Treg cells7,10,11 such that the propor-
tion of Treg cells in the stressed mice is reduced after
the culture with allergen, whereas it is not different in
the non-stressed mice.
In conclusion, we produced mice that express
MORs only on noradrenergic and adrenergic neu-
rons, and we confirmed the contribution of MORs in
the CNS to restraint stress-induced worsening of al-
lergic airway inflammation. We also demonstrated
that upon allergen stimulation, the profile of cytokine
production was more Th2 dominated and the devel-
opment of Treg cells was reduced in BLN cells from
allergic mice exposed to restraint stress, and that
MORs were involved in these immunological altera-
tions induced by stress exposure. The mechanisms
by which the activation of MORs induced the altera-
tions of immune responses to allergen were not de-
termined in the current study. Further investigations,
including functional analysis and adoptive transfer of
BLN cells from wild-type and MORKO mice with or
without stress, are needed to clarify the pathways
linking psychological stress to asthma exacerbation
in terms of a neuro-immunological cascade.
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